Among the photos in this article is the one on the right from Dr. Burgess that shows how severely a person of color (African American in this case) can get impacted by problems such as post-inflammatory hyperpigmentation (PIH). The authors also outline differences in the facial skin aging of people of the main ethnicities in the US (White, Black, Hispanic and Asian). Moreover, morphological differences and varying cultural preferences mean that even people of color can not be considered as a monolithic entity (in terms of desired outcomes from surgeries and procedures).
Some conditions are more common in certain ethnicities (e.g., seborrheic keratoses in African American women). Different racial and ethnic groups are also more of less likely to suffer from post-inflammatory hyperpigmentation (PIH). The authors suggest focusing on other measures of skin types besides the most popular Fitzpatrick (FST) scale. Among alternatives include the Roberts Skin Type Classification System (RSTCS). This is a 4-part scale that is used to “assess and assign a numerical value to a patient’s phototype, hyperpigmentation, photoaging, and scarring capability”.
There now exist a wide range of cosmeceutical agents for people of color (POC). These can be used for pre-procedure and post-procedure management, as well as to address daily cosmetic concerns. I will be writing about these in detail on this blog in separate posts in the coming months. Note that even some non-prescription strength skin lightening creams can cause side effects with overuse, so always consult a dermatologist before use.
In this JAAD paper, the authors highlight some cosmeceutical agents and melanogenesis inhibitors that are popular in treating hyperpigmentation in darker skin types. Most of these act as tyrosinase inhibitors.
When it comes to anti-aging, among the products that are commonly used by people of color include: antioxidants, peptides and growth factors. Photoprotection via sunscreen use is significantly lacking in the black population.